keyword
https://read.qxmd.com/read/38123875/rapid-improvements-in-itch-with-tapinarof-cream-1-once-daily-in-two-phase%C3%A2-3-trials-in-adults-with-mild-to-severe-plaque-psoriasis
#21
JOURNAL ARTICLE
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, Tomas Chao, Philip M Brown, David S Rubenstein, Anna M Tallman
INTRODUCTION: Patients with psoriasis report pruritus as their most bothersome symptom. Tapinarof cream 1% once daily demonstrated significant efficacy versus vehicle and was well tolerated in adults with mild to severe plaque psoriasis in two 12-week trials: PSOARING 1 (NCT03956355) and PSOARING 2 (NCT03983980). Here, we present patient-reported pruritus outcomes from these trials. METHODS: Outcomes included a Peak Pruritus Numerical Rating Scale (PP-NRS) score of 0 or 1 (itch-free state); Dermatology Life Quality Index (DLQI) itch item scores; and Psoriasis Symptom Diary (PSD) itch item scores...
December 21, 2023: Dermatology and Therapy
https://read.qxmd.com/read/38085369/evaluation-of-curcumin-for-dermatologic-conditions-a-systematic-review
#22
REVIEW
Paras Patel, Jennifer Y Wang, Jessica Mineroff, Jared Jagdeo
There is increasing demand for natural and sustainable products for the treatment of dermatologic conditions. This systematic review aims to critically analyze published randomized controlled trials (RCTs) and provide evidence-based recommendations on the therapeutic use of curcumin for a variety of dermatological diseases. A systematic search of published literature was performed on July 18, 2023 using PRISMA guidelines for turmeric or curcumin for the treatment of skin diseases. Clinical recommendations were made based on the Oxford Centre for Evidence-Based Medicine guidelines...
December 12, 2023: Archives of Dermatological Research
https://read.qxmd.com/read/38035099/oncostatin-m-suppresses-il31ra-expression-in-dorsal-root-ganglia-and-interleukin-31-induced-itching
#23
JOURNAL ARTICLE
Masataka Suehiro, Tomofumi Numata, Ryo Saito, Nozomi Yanagida, Chie Ishikawa, Kazue Uchida, Tomoko Kawaguchi, Yuhki Yanase, Yozo Ishiuji, John McGrath, Akio Tanaka
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intermittent itchy rash. Type 2 inflammatory cytokines such as interleukin (IL)-4, IL-13, and IL-31 are strongly implicated in AD pathogenesis. Stimulation of IL-31 cognate receptors on C-fiber nerve endings is believed to activate neurons in the dorsal root ganglion (DRG), causing itch. The IL-31 receptor is a heterodimer of OSMRβ and IL31RA subunits, and OSMRβ can also bind oncostatin M (OSM), a pro-inflammatory cytokine released by monocytes/macrophages, dendritic cells, and T lymphocytes...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38024914/association-of-pruritus-with-sleep-in-patients-with-psoriasis-and-chronic-spontaneous-urticaria-a-cross-sectional-study
#24
JOURNAL ARTICLE
Prakriti Shukla, Parul Verma, Srishti Tripathi, Alok K Dwivedi, Mukesh Shukla, Swastika Suvirya
BACKGROUND: Pruritus is a frequent complaint associated with various inflammatory dermatoses. Sleep is often disturbed because of pruritus but the impact of severity and diurnal pattern of pruritus has not been studied so far. OBJECTIVES: To estimate the prevalence of nocturnal itch (NI) and its association with itch severity, sleep disturbance and quality of life (QoL) compared with non-NI in chronic plaque psoriasis (CPP) and chronic spontaneous urticaria (CSU)...
September 2023: Journal of Family Medicine and Primary Care
https://read.qxmd.com/read/38007440/imiquimod-induced-pruritus-in-female-wild-type-and-knockin-wistar-rats-underscoring-behavioral-scratching-in-a-rat-model-for-antipruritic-treatments
#25
JOURNAL ARTICLE
Karen Lariosa-Willingham, Dmitri Leonoudakis, Florian Simon, Kendall Walker, Philippe Guillaume, Liling Warren, Jennifer Stratton
OBJECTIVES: Animal models of skin disease are used to evaluate therapeutics to alleviate disease. One common clinical dermatological complaint is pruritus (itch), but there is a lack of standardization in the characterization of pre-clinical models and scratching behavior, a key itch endpoint, is often neglected. One such model is the widely used imiquimod (IMQ) mouse model of psoriasis. However, it lacks characterized behavioral attributes like scratching, nor has widely expanded to other species like rats...
November 25, 2023: BMC Research Notes
https://read.qxmd.com/read/38003712/cannabinoids-and-their-receptors-in-skin-diseases
#26
REVIEW
Eun Hee Yoo, Ji Hyun Lee
The therapeutic application of cannabinoids has gained traction in recent years. Cannabinoids interact with the human endocannabinoid system in the skin. A large body of research indicates that cannabinoids could hold promise for the treatment of eczema, psoriasis, acne, pruritus, hair disorders, and skin cancer. However, most of the available data are at the preclinical stage. Comprehensive, large-scale, randomized, controlled clinical trials have not yet been fully conducted. In this article, we describe new findings in cannabinoid research and point out promising future research areas...
November 20, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37996010/me3183-a-novel-phosphodiesterase-4-inhibitor-exhibits-potent-anti-inflammatory-effects-and-is-well-tolerated-in-a-non-clinical-study
#27
JOURNAL ARTICLE
Natsuki Kubota-Ishida, Chizuko Kaji, Shogo Matsumoto, Tsubasa Wakabayashi, Takashi Matsuhira, Iori Okura, Naoki Cho, Satoshi Isshiki, Ko Kumura, Yuji Tabata
Phosphodiesterase 4 (PDE4) inhibitors are expected to exhibit efficacy against inflammatory diseases due to their broad pharmacological activity. The launched PDE4 inhibitors apremilast, crisaborole, and roflumilast have not exhibited sufficient inhibitory potential due to poor margins of effectiveness and tolerability. In this report, we describe the non-clinical efficacy, brain translocation, and vomit-inducing effects of ME3183 compared with apremilast. ME3183 showed extensive cytokine suppression in vitro studies using human peripheral blood mononuclear cells and T cells...
January 5, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/37942041/a-rare-case-report-chronic-generalized-idiopathic-pruritus
#28
Iya Agha, Emmanuel Khodra, Ryan Cornell, Jaskaran Ghotra, Noor Asif, Saif Aldeen Agha, Ayad K M Agha
BACKGROUND: Generalized chronic pruritus (CP) can be associated with seborrheic dermatitis and psoriasis but often can present without any noticeable diagnosis or obvious skin lesion. When not related to a clear diagnosis, CP can be characterized as idiopathic pruritus. CP is both a diagnostically and therapeutically challenging presentation due to the variety of systemic, dermatological, neurological, and psychogenic diseases that must be ruled out before diagnosing idiopathic pruritus...
2023: AME Case Reports
https://read.qxmd.com/read/37908643/childhood-guttate-psoriasis-an-updated-review
#29
REVIEW
Alexander Kc Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong
BACKGROUND: Guttate psoriasis is common and affects 0.5-2% of individuals in the paediatric age group. This review aims to familiarize physicians with the clinical manifestations, evaluation, diagnosis and proper management of guttate psoriasis. METHODS: A search was conducted in July 2023 in PubMed Clinical Queries using the key term "guttate psoriasis". The search strategy included all observational studies, clinical trials and reviews published within the past 10 years...
2023: Drugs in Context
https://read.qxmd.com/read/37852247/epidemiology-and-comorbidity-of-patients-with-alopecia-areata-in-germany-analysis-of-longitudinal-claims-data
#30
JOURNAL ARTICLE
Matthias Augustin, Nesrine Ben-Anaya, Katharina Müller, Kristina Hagenström
BACKGROUND: Alopecia areata (AA) is a chronic, immune-mediated disease characterised by acute onset hair loss. The hair loss can range from small, circumscribed hairless areas on the scalp to complete loss of head and body hair. However, data on the epidemiology of AA are limited. Current evaluations are lacking in Germany. The aim of this study was to evaluate the epidemiology and comorbidity of AA in Germany based on claims data. METHODS: A representative 40% sample of all adults who were insured with a German statutory health insurance (DAK-G) between 2016 and 2020 was evaluated (n = 2...
October 19, 2023: British Journal of Dermatology
https://read.qxmd.com/read/37845323/evaluation-of-sleep-quality-and-pruritus-severity-in-psoriatic-patients-and-their-impact-on-quality-of-life-a-cross-section-correlational-study
#31
JOURNAL ARTICLE
Mohamed S Zaky, Emad Eldin A Elgamal, Ayman A Abd Al Maksoud, Dina H Mohamed, Mohamed L Elsaie
Psoriasis is a chronic inflammatory condition associated with genetic and immunological susceptibility. The objective of the study was to evaluate pruritus and sleep quality in correlation (r) to psoriasis severity and to detect their impact on quality of life. Two hundred (200) patients with psoriasis were included. Psoriasis severity was determined using the psoriasis area severity index (PASI), the quality of life (QoL) was assessed by the psoriasis disability index (PDI) questionnaire, and the sleep quality was evaluated by the Pittsburgh sleep quality index (PSQI)...
October 16, 2023: Scientific Reports
https://read.qxmd.com/read/37837493/efficacy-of-av%C3%A3-ne-hydrotherapy-on-chronic-pruritus-in-patients-with-plaque-psoriasis
#32
JOURNAL ARTICLE
Marie-Dominique Thouvenin, Adeline Bacquey, Marine Babin, Fabrice Lestienne, Christophe Lauze, Eléonore Gravier, Diana Placintescu, Ariadna Ortiz-Brugués, Sonja Ständer
INTRODUCTION: Pruritus is a prevalent symptom, described as one of the most bothersome of psoriasis. Specific itch management remains a challenge, for which hydrotherapy could be used as adjunct care to medical treatment. Therefore, we assessed the immediate and longer-term benefit of 3 weeks of Avène thermal spring water hydrotherapy on chronic pruritus in patients in addition to their usual psoriasis and/or pruritus management. METHODS: Twenty-six patients suffering from chronic pruritus due to psoriasis were evaluated before and after 3 weeks of hydrotherapy with a 3 and 6 month follow-up...
October 14, 2023: Dermatology and Therapy
https://read.qxmd.com/read/37834183/pathomechanism-of-pruritus-in-psoriasis-and-atopic-dermatitis-novel-approaches-similarities-and-differences
#33
REVIEW
Agnieszka Kaczmarska, Dominika Kwiatkowska, Katarzyna Konstancja Skrzypek, Zbigniew Tadeusz Kowalewski, Kamila Jaworecka, Adam Reich
Pruritus is defined as an unpleasant sensation that elicits a desire to scratch. Nearly a third of the world's population may suffer from pruritus during their lifetime. This symptom is widely observed in numerous inflammatory skin diseases-e.g., approximately 70-90% of patients with psoriasis and almost every patient with atopic dermatitis suffer from pruritus. Although the pathogenesis of atopic dermatitis and psoriasis is different, the complex intricacies between several biochemical mediators, enzymes, and pathways seem to play a crucial role in both conditions...
September 29, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37829299/harder-better-faster-stronger-retrospective-chart-review-of-adverse-events-of-interactions-between-adaptogens-and-antidepressant-drugs
#34
JOURNAL ARTICLE
Marcin Siwek, Jarosław Woroń, Anna Wrzosek, Jarosław Gupało, Adrian Andrzej Chrobak
Aim: We aimed to systematically evaluate the prevalence and clinical characteristics of adverse events associated with the adaptogens and antidepressant drug interactions in a retrospective chart review. Methodology: A total of 1,816 reports of adverse events were evaluated. Cases were included in the analysis if the pharmacoepidemiological analysis showed the presence of a high probability of a causal relationship between an adaptogen and antidepressant interaction and the occurrence of adverse events. The following data were extracted from the reports: age, sex, antidepressant, plant products containing adaptogens, other concomitant medications, and clinical consequences of the interactions and their possible mechanisms...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37762940/the-psoriasis-disability-index-in-romanian-psoriasis-patients-during-covid-19-pandemic-contribution-of-clinical-and-psychological-variables
#35
JOURNAL ARTICLE
Carina Mihu, Codruța Alina Popescu, Maria Adriana Neag, Ioana Corina Bocşan, Carmen Stanca Melincovici, Adrian Lucian Baican, Bogdana Adriana Năsui, Anca-Dana Buzoianu
BACKGROUND: Psoriasis is one of the most frequent chronic inflammatory skin diseases and has a negative impact on the interpersonal relationship and psychosocial well-being. The aims of this study were to examine the effects of intensity of pruritus on quality of life and depression, to investigate the relationship between anger, self-esteem, and depression, and to compare patients with early and late onset of psoriasis. As our study was carried out during the COVID-19 pandemic, we aimed also to investigate the safety concerns and anxiety related to COVID-19 in psoriasis patients...
September 16, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37703833/cold-atmospheric-plasma-a-promising-and-safe-therapeutic-strategy-for-atopic-dermatitis
#36
REVIEW
Fan Bai, Yutong Ran, Siyue Zhai, Yumin Xia
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Microbial infection, immune system dysfunction, and skin barrier defunctionalization have been regarded as the central events in AD pathogenesis. Cold atmospheric plasma (CAP) is an unbound system composed of many free electrons, ions, and neutral particles, with macroscopic time and spatial scales. Based on dielectric barrier discharge, glow discharge, corona discharge, or arch discharge, CAP is generated at normal atmospheric pressure. Its special physical properties maintain its temperature at 20°C-40°C, combining the advantages of high safety and strong ionic activity...
September 13, 2023: International Archives of Allergy and Immunology
https://read.qxmd.com/read/37630401/therapeutic-potential-of-minor-cannabinoids-in-dermatological-diseases-a-synthetic-review
#37
REVIEW
Emilia Kwiecień, Dorota Kowalczuk
Dermatological diseases pose a significant burden on the quality of life of individuals and can be challenging to treat effectively. In this aspect, cannabinoids are gaining increasing importance due to their therapeutic potential in various disease entities including skin diseases. In this synthetic review, we comprehensively analyzed the existing literature in the field of potential dermatological applications of a lesser-known subgroup of cannabinoids, the so-called minor cannabinoids, such as cannabidivarin (CBDV), cannabidiforol (CBDP), cannabichromene (CBC), tetrahydrocannabivarin (THCV), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabielsoin (CBE), cannabimovone (CBM) or cannabinol (CBN), while drawing attention to their unique pharmacological properties...
August 20, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/37574153/chronic-eyelid-and-ocular-itch
#38
JOURNAL ARTICLE
Eric J Beltrami, Andrzej Grzybowski, Jane M Grant-Kels
Chronic eyelid and ocular itch affect many patients seeking dermatologic or ophthalmologic care and have a high burden on patient quality of life. Clinicians should consider the broad range of possible diagnoses when approaching the patient with itch of the eyes or eyelids lasting more than 6 weeks. Allergic conjunctivitis and allergic contact dermatitis are the most common causes of chronic itch of the eyes and eyelids, respectively. Other diagnoses to consider include atopic dermatitis, xerosis, neurogenic itch, dry eye syndrome, seborrheic dermatitis, blepharitis, rosacea, lichen simplex chronicus, and papulosquamous disorders...
August 11, 2023: Clinics in Dermatology
https://read.qxmd.com/read/37554981/characteristic-analysis-of-adverse-reactions-of-five-anti-tnf%C3%A9-agents-a-descriptive-analysis-from-who-vigiaccess
#39
JOURNAL ARTICLE
Mingming Li, Ruxu You, Yuyong Su, Hongbo Zhou, Shiwei Gong
Introduction: Tumor necrosis factor (TNF) inhibitors (adalimumab, infliximab, etanercept, golimumab, and certolizumab pegol) have revolutionized the treatment of severe immune-mediated inflammatory diseases, including rheumatoid arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This study assessed adverse drug reactions (ADRs) after the use of TNFα inhibitors in VigiAccess of the World Health Organization (WHO) and compared the adverse reaction characteristics of five inhibitors to select the drug with the least risk for individualized patient use...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37511476/a-transcriptome-wide-analysis-of-psoriasis-identifying-the-potential-causal-genes-and-drug-candidates
#40
JOURNAL ARTICLE
Yeonbin Jeong, Jaeseung Song, Yubin Lee, Eunyoung Choi, Youngtae Won, Byunghyuk Kim, Wonhee Jang
Psoriasis is a chronic inflammatory skin disease characterized by cutaneous eruptions and pruritus. Because the genetic backgrounds of psoriasis are only partially revealed, an integrative and rigorous study is necessary. We conducted a transcriptome-wide association study (TWAS) with the new Genotype-Tissue Expression version 8 reference panels, including some tissue and multi-tissue panels that were not used previously. We performed tissue-specific heritability analyses on genome-wide association study data to prioritize the tissue panels for TWAS analysis...
July 20, 2023: International Journal of Molecular Sciences
keyword
keyword
14346
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.